JAN 11, 2017 4:46 PM PST

Insight Into how Cancer Cells Overcome Abnormalities & Grow

WRITTEN BY: Carmen Leitch

In the following video from the Francis Crick Institute, you can get a look at why cancer cells are able to proliferate rapidly despite chromosomal abnormalities. It is based on two new papers, one published in Cancer Cell and one in Cancer Discovery.

Normally, healthy cells will self-destruct if it has genetic damage that can’t be fixed, and that damages DNA won’t be passed on. In cancer cells, however, where there is myriad genetic disorder, they are still able to replicate and spread. During their growth they are also able to evade treatment strategies.

One of the studies, in Cancer Discovery, showed that cancerous cells have to avoid accumulating too much damage, as there seems to be a limit to what is tolerable. In that work, researchers reported that cancer cells are able to get by while carrying myriad chromosomal abnormalities because of a slowdown in cellular machinery called APC/C. The cancerous cells can thus get away without making too many mistakes with their daughter cells, increasing genetic diversity in a tumor.

"The development and progression of cancer is fuelled by an unstable genome. It can cause a high degree of diversity between cells, influencing how well treatments work and drug resistance. If a cancer cell can cope with large scale changes to its DNA then it might gain an advantage that helps it to grow, spread and survive treatment. Until now, we knew very little about how these cancer cells kept growing and evolving,” said Professor Charles Swanton, who led the research team at the Francis Crick Institute in London.

"We hope that understanding these mechanisms will allow us to limit drug resistance and improve the efficacy of cancer therapies," he continued.

The other work, in Cancer Cell, showed an increase in mutations in a specific gene in cancerous bowel cells. In normal cells, that gene, BCL9L, helps activate a protein involved in the cell’s self-destruct mechanism. When BCL9L was inactivated, cells with an uneven number of chromosomes were able to continue otherwise normal growth.

In patients that carry tumor cells with an incorrect number of chromosomes, there can be worse outcomes because of cancer evolution and resistance to drug therapies.

"These two studies reveal more about how cancer cells are able to survive with a genetic makeup that would lead to the death of normal cells. This opens the door to potentially exciting new ways to target cancer cells - by exploiting the genetic chaos that lies at the heart of some cancers,” commented Professor Karen Vousden, Chief Scientist at Cancer Research UK.

 

Sources: Francis Crick Institute, Cancer Cell, Cancer Discovery

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 20, 2021
Clinical & Molecular DX
Stressed Out Pregnant Mothers More Likely to Have Girls
APR 20, 2021
Stressed Out Pregnant Mothers More Likely to Have Girls
Scientists from the University of Granada used hair samples to monitor cortisol in a cohort of over 100 pregnant women a ...
MAY 18, 2021
Genetics & Genomics
The Oral Microbiome Reveals How Long We've Loved Starchy Foods
MAY 18, 2021
The Oral Microbiome Reveals How Long We've Loved Starchy Foods
Bacteria are everywhere, including our guts and mouths. Researchers are learnings more about the history of the human mi ...
JUN 02, 2021
Genetics & Genomics
A Genetic Form of ALS is Discovered
JUN 02, 2021
A Genetic Form of ALS is Discovered
Some medical mysteries have become much easier to solve because of advanced genetic techniques that have enabled researc ...
JUN 03, 2021
Microbiology
How HIV Can Deplete White Matter in the Brain
JUN 03, 2021
How HIV Can Deplete White Matter in the Brain
The brain is sometimes called grey matter, which is made up of neurons. But it also contains white matter, which are neu ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
Loading Comments...